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Gamma-glutamyl transpeptidase (yGT) has been
widely used by many investigators as a useful
histoenzymic marker for preneoplastic
hepatocellular lesions during experimental
hepatocarcinogenesis (Kalengayi et al., 1975, Hirota
& Williams, 1979, Farber, 1980), since the
appearance of this enzyme in rodent livers exposed
to hepatocarcinogens was reported as an oncofoetal
property by Fiala et al. (1972). We recently
demonstrated a rather widespread histochemical
distribution of yGT activity in various kinds of
human thyroid lesions, either neoplastic or non-
neoplastic, with little or no activity present in the
normal thyroid tissues and with the strongest
reaction for yGT occurring in papillary carcinoma
among the thyroid neoplasms (Moriyama et al.,
1982). In the present study, a significant yGT
activity was found in putative precancerous thyroid
lesions in rats treated with thyroid carcinogen.
Injection (s.c.) of diisopropanolnitrosamine
(DIPN, Nakarai Chem., Ltd., Kyoto) 750mgkg-t
was given, once weekly for 10 weeks, to 7 male and
4 female Wistar rats, weighing 400g and 300g,
respectively. Animals were maintained on a
commercial diet (CE-2, Oriental Yeast, Co., Ltd.,
Tokyo) throughout the experiment. One male
animal was sacrificed at 5 weeks after the
commencement of the experiment. Two males were
killed at 10 weeks and the remainder of the males
and all the females at 18 weeks. At autopsy, the
thyroid tissues were removed immediately. Frozen
sections (6tm) were prepared in a cryostat for
histochemical staining of yGT as described by
Rutenburg et al. (1968).
No yGT activity was present in the thyroid
tissues from untreated control rats, except for a
positive yGT stain in the squamous epithelial nests.
As early as 5 weeks after the first injection of
DIPN, the thyroid glands showed, microscopically,
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diffuse hyperplasia of small thyroid follicles. The
thyroid glands in 2 animals killed at 10 weeks were
similarly hyperplastic. yGT staining remained
negative in these hyperplastic follicles. At 18 weeks
focal proliferative lesions of atypical cells with
prominent nuclei (designated "altered foci"),
characterized by the appearance of ectatic follicular
structures, were found within the hyperplastic
thyroid tissues. Some of these "altered foci" were
strongly positive for yGT (Figure 1), while the other
foci were weakly positive or even negative. Nodular
proliferative lesions (designated "neoplastic
nodules"), which exhibited strong activity of yGT
(Figure 2), also occurred at 18 weeks. Some foci
were present around the nodules. Three out of 4
male rats exhibited either foci or nodules at 18
weeks. Among these, 6 out of an aggregate of 17
foci were yGT positive, as were 2 nodules one of
which was present in each of 2 rats. By contrast,
only diffuse hyperplasia of the thyroid with no
yGT-positive lesions was observed in the female rats
at 18 weeks, indicating that in the latter the thyroid
as a target organ is either less sensitive to DIPN or
the enzymes metabolizing the agent are present to a
much lesser extent since the ultimate carcinogen is a
metabolite of DIPN.
This is the first report to our knowledge on the
occurrence of yGT activity in the atypical
proliferative focal or nodular lesions in thyroids
during experimental thyroid carcinogenesis. These
discrete yGT-positive lesions induced by a long-
term treatment with DIPN, which is known to be a
thyroid carcinogen (Mohr et al., 1977), are
reminiscent of altered (hyperplastic) foci or
neoplastic (hyperplastic) nodules during hepato-
carcinogenesis. In view of the morphological
features and yGT staining, we consider that "altered
foci" or "neoplastic nodules" of the thyroid in rats
treated with DIPN are possibly precancerous in
nature. Mohr et al. (1977) reported that DIPN at
the same dose level as employed in the present
experiment induced thyroid cancer 26 weeks
following the initial injection. However, so far, no
histoenzymatically altered foci or nodules have been
described. Because increased yGT activity has not
© The Macmillan Press Ltd., 1983Figure 1 A yGT-positive "altered focus" (in the lower left) in the thyroid of a male rat at 18 weeks after the
initial DIPN treatment. A squamous epithelial nest also showing positive staining (in the upper right). yGT
reaction without counterstain. x 240.
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Figure 2 Strong yGT activity in a "neoplastic nodule" surrounded by hyperplastic thyroid tissues in a male
rat at 18 weeks after the initial DIPN treatment. yGT reaction, counterstained with hematoxvlin. x 160.
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been documented in rat foetal thyroid tissue,
discussion of the oncofoetal property of this enzyme
in the thyroid is not relevant. Nevertheless, the
situation seems close to that of experimental
hepatocarcinogenesis in rats, in which yGT is a
significant histoenzymic marker of preneoplastic or
neoplastic changes, with an implication of induction
of foetal enzymic activity. These preliminary data
suggest that yGT might be a useful, functional
marker for preneoplastic changes in experimental
thyroid carcinogenesis.
The authors are grateful to Miss Hideko Oh-hashi for her
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